

* Department of Pediatrics, University College London Medical School, Bloomsbury Campus, London, United Kingdom
Neurosciences Unit, Institute of Child Health, University College London Medical School, Mecklenburgh Square, London, United Kingdom
| ABSTRACT |
|---|
|
|
|---|
Methods. Eight hundred forty-seven infants born at <33 weeks of gestation, admitted to a single tertiary referral center between 1983 and 1988, underwent serial neonatal cranial ultrasound. At 8 years of age neurodevelopmental outcome was assessed by structured neurologic examination, psychometric tests (Wechsler Intelligence Scale for Children), tests of visuomotor integration (Beery) and motor impairment (Henderson-Stott). Infants were subdivided into a group born at <28 weeks and a group born at between 28 and 32 weeks. Neurodevelopmental outcome was analyzed for each ultrasound diagnosis.
Results. Hemorrhagic lesions such as germinal matrix/intraventricular hemorrhage and hemorrhagic parenchymal infarction were more frequent in infants born at <28 weeks. There was no difference in the frequency of cystic periventricular leucomalacia between the 2 groups. When neurodevelopmental outcome for each ultrasound diagnosis was compared, no significant difference was found between the 2 gestational age groups.
Conclusion. In the gestational age range studied, adverse neurodevelopmental outcome depends primarily on the type of the intracranial lesion rather than on gestational age.
Key Words: very preterm infant neonatal cranial ultrasound neurodevelopmental outcome brain lesions gestational age
Abbreviations: SD, standard deviation WISC, Wechsler Intelligence Scale for Children GMH/IVH, germinal matrix/intraventricular hemorrhage PVL, periventricular leukomalacia HPI, hemorrhagic parenchymal infarction
As a result of advances in perinatal management, survival for infants born before 32 weeks of gestation is continuing to increase. However, rates of neurodevelopmental impairments have remained substantially unchanged,13 and the long-term outcome of extremely immature infants remains a major concern. For example, school performance of infants weighing <1000 g is suboptimal when compared both with their term peers and with infants weighing between 1000 and 1500 g.47 Most neurodevelopmental impairments are likely to be the consequence of brain damage of perinatal origin, and the majority of these lesions can be identified in the neonatal period with the use of cranial ultrasound.8,9 As a result, ultrasound detection of brain lesions has proved very useful for providing early prognostic information about outcome in childhood.1012 Several studies have reported the impact of individual lesions on neurodevelopmental outcome.11,1316 At the same time, a number of studies have shown that gestational age and neurodevelopmental outcome are closely related, with the worst outcome in infants born at the lowest gestational ages (for review, see ref 3). Although implicit in other studies, no previous study has specifically addressed this issue by looking at neurodevelopmental outcome of preterm infants with the same lesion at different gestational ages.
The aims of this study were, first, to establish the frequency of ultrasound-detected brain lesions at different gestational ages in infants born before 33 weeks of gestation and, second, to investigate whether the relationship between these lesions and neurodevelopmental outcome at 8 years of age was independent of gestational age.
| METHODS |
|---|
|
|
|---|
Neonatal Cranial Ultrasound
Cranial ultrasound investigations were performed daily for the first 5 days of life and then weekly until discharge. A mechanical sector scanner (Diasonics DS1, Siemens, Erlangen, Germany) was used between 1983 and 1986, with a 5-, 6-, or 7.5-MHz probe. After 1987, an Ultramark 4 Scanner (Siemens, Erlangen, Germany) was used with a 7.5-MHz probe for routine use and a 10-MHz probe to clarify suspicious findings. The images were stored on videotape. These tapes were reviewed by at least 2 experienced observers, and the diagnosis was agreed by consensus. The definitions for the ultrasound diagnoses are given in Appendix 1.
Follow-up
Surviving infants were enrolled in a prospective follow-up program. Neurodevelopmental outcome was assessed at 8 years of age by investigators who were blind to the ultrasound diagnoses. Details of these assessments have been published elsewhere12,13 and are summarized in Appendix 2. Based on the findings at these assessments, the children were assigned to 1 of 3 outcome categories. These outcome categories were 1) no neurodevelopmental impairment; 2) impairment but without disability (neuromotor impairment without functional consequences, high-tone hearing loss without requirement for aiding, or IQ 7079); 3) impairment with disability (neuromotor impairment with functional consequences, sensory neural hearing loss requiring aiding, blind or registered partially sighted, IQ >2 standard deviations (SDs) below the test mean or requirement for formal educational provision). If a childs disabilities were sufficiently severe to prevent completion of the tests, then the arbitrary test result was assigned at 3 SDs below the mean for the Wechsler Intelligence Scale for Children-Revised (WISC-R)/Wechsler Intelligence Scale for Children-III (WISC-III) and below the 5th centile for the Beery test, and a maximum error score was assigned for the Henderson-Stott Test of Motor Impairment, as discussed previously.13
To investigate the effect of gestation, the cohort was divided into two groups: group A comprised all infants born before 28 weeks of gestation and group B comprised all infants born between 28 and 32 weeks of gestation.
Statistics
The data were analyzed with SPSS for Windows (version 7.5). Group differences were analyzed by using the
2 test, Fisher Exact Test, and Student t test.
Ethics
This study was part of a long-term follow-up program for very preterm infants for which approval was given by the Joint University College London/University College London Hospitals Committees on the Ethics of Human Research.
| RESULTS |
|---|
|
|
|---|
|
|
The ultrasound diagnoses of those children who could not be assessed at 8 years of age ("lost to follow-up") are given in Table 2.
|
|
We further analyzed the data to see if the timing of death had a significant impact on the distribution of lesions with gestation. Infants who died before 2 weeks of age were compared with those who died after 2 weeks of age. The purpose of this analysis was to take into account the fact that cystic PVL takes longer to develop. Table 4 shows the results of this analysis. In group A only, GMH/IVH (P = .004), flare (P = .05), ventricular dilatation (P = .04), hydrocephalus (P = .001), and the combination of GMH/IVH with flare and ventricular dilatation (P = .04) were significantly more common in infants who died before 2 weeks of age. Cystic PVL was significantly more frequent (P = .025) in those who died after 2 weeks of age. It has to be kept in mind, however, that there were only 2 infants with cystic PVL who died in either gestational age group. Therefore, this result must treated with caution. There was no significant difference for normal ultrasound scans or HPI. In contrast, in group B, flare was the only ultrasound lesion that was significantly different (P = .003) between early and late death.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Intracranial Lesions and Gestational Age
Our data suggest that, in this cohort of very preterm infants, hemorrhagic lesions were particularly associated with birth at very low gestational age, whereas cystic periventricular leucomalacia was evenly distributed between 24 and 32 weeks of gestation. We suspected that this finding might be the result of the time taken for the lesions to become visible on cranial ultrasound scanning, and that the true prevalence of cystic PVL could, as a result, have been underestimated in those who died early. We found more cystic PVL in the very immature infants who died after 2 weeks, but this difference was not apparent in the more mature age group. However, because there were only 2 infants with cystic PVL who died in either gestation group, these results have to be interpreted with caution. Nevertheless, it seems likely that the time of death was not the only explanation for the difference in the frequency of hemorrhagic and ischemic lesions. In surviving infants, serial ultrasound examinations were continued at least up to term, so that it is unlikely that we failed to identify lesions, such as localized cystic PVL, which can develop beyond the first month of life.16,17 Ultrasound equipment has changed over time and, with the use of mechanical-sector scanning, detection of PVL has been become more reliable. Roth et al18 demonstrated that the change of equipment, however, has not had a significant effect on the accuracy of prediction of neurodevelopmental outcome. Furthermore, a change in the ability of detecting lesions would have affected both groups in the same way.
Other studies have also found that gestational age is an independent risk factor for the development of both hemorrhagic and ischemic lesions.19,20 DeVries et al20 found an increased incidence of extensive cystic PVL in the more mature infants, whereas pure hemorrhagic lesions were more common in the most immature infants. The changing frequency of hemorrhagic lesions with gestational age is most likely caused by physiologic changes and maturation of the vascular system, especially changes in the subependymal matrix.21 The equal distribution of ischemic lesions across the gestational age groups in our study is probably indicative of different etiologic processes in the development of the two pathologies. The mechanisms underlying the vulnerability of very preterm infants to periventricular white matter injury are a matter of continuing debate.2123
Ultrasound Diagnosis, Gestational Age, and Neurodevelopmental Outcome at 8 Years
As in many previously published studies (for review, see Hack and Fanaroff3), we found that children in the lower gestational age group were more likely to develop neurodevelopmental impairments. In both groups the proportion of children with impairments seems high, but it must be borne in mind that, in the "all-impairments" group, children with any impairment were included (nondisabling and disabling) and that a great number of children in this group had only minor impairments.
Overall neurodevelopmental outcome at the age of 8 years was not different when both groups were compared within each ultrasound diagnosis.
Our results suggest that the increased risk of impairment in the group born before 28 weeks of gestation was primarily attributable to an increased incidence of hemorrhagic lesions in the most immature infants, and that gestational age in itself does not have an independent effect on neurodevelopmental outcome for the child with a specific lesion.
It could be speculated that injury to the very immature brain might lead to more potential for recovery and, hence, intracranial lesions in the very young infants might be associated with less severe long-term outcome. Our data, however, fail to support this. Neuropathologic studies have shown that injuries to the transient fetal subplate zone, which contains "waiting" axons and neurons, result in disruption of processes that are essential for normal brain organization.24,25 The subplate zone has its developmental peak between 22 and 34 weeks of gestation.21 Hence, intracranial lesions that affect the subplate zone in the 2 gestational age groups we studied may have similar adverse effects on brain organization and subsequent outcome.
In summary, the results of this study suggest that, in very preterm infants born between 24 and 32 weeks of gestation, the risk of adverse overall neurodevelopmental outcome depends primarily on the presence and type of intracranial lesion. Although there is some controversy,26 our data suggest that if further methods to reduce the incidence of hemorrhagic lesions in the most immature infants can be found, this may be expected to lead to improvement in their long-term outcome.
| APPENDIX 1: DEFINITION OF INDIVIDUAL CRANIAL ULTRASOUND LESIONS27 |
|---|
|
|
|---|
Subependymal pseudocyst (SEPC). Cystic degeneration within a germinal-layer hemorrhage without cystic changes in the surrounding brain parenchyma.
Hemorrhagic parenchymal infarction (HPI). Markedly increased echodensities within the brain parenchyma, wedge shaped, and extending from the ventricular margin, in association with an ipsilateral GMH/IVH.
Periventricular flare (PVF). Abnormally increased echodensities in the periventricular white matter without an ipsilateral GMH/IVH.
Cystic PVL. Cystic lesion within the periventricular white matter, not preceded by HPI at the same site.
Ventricular dilatation. Dilatation of the lateral ventricle with cerebrospinal fluid such that the depth of the frontal horn immediately anterior to the thalamocaudate notch is >3 mm (97th centile).28
Posthemorrhagic hydrocephalus. Marked pressure-driven dilatation of a lateral ventricle with cerebrospinal fluid such that its width is 5 mm or more above the 97th centile for this.28
Loss of brain tissue. Loss of brain tissue from any cause, including cystic PVL, porencephalic cyst following HPI, irregular enlargement of the lateral ventricles, and generalized cerebral atrophy. Does not include isolated subependymal pseudocyst.
| APPENDIX 2: FOLLOW-UP PROTOCOL AT 8 YEARS OF AGE |
|---|
|
|
|---|
Structured neurologic examination29
Pure-tone audiogram
Vision test (Snellen`s charts)30
Henderson-Stott Test of Motor Impairment (TOMI)31
Beery test of visual-motor integration32
Wechsler Intelligence scales for children33,34
(WISC-R was used for children born between 1983 and 1986 and WISC-III, for children born in 1987 and 1988.)
| NONSYMPTOM DRIVEN IMAGING |
|---|
|
|
|---|
"But there is a more sinister danger. Because of medical setting and on-site medical expertise are not necessary for our new imaging techniques, the ties between the medical indications for a particular test and the motives for carrying it out are inevitably loosened. And thus the opportunity for financial gain moves into conflict with clinical need."
Hayward R. VOMIT (victims of modern imaging technology): an acronym for our times. BMJ. 2003;326:1273
Submitted by Student
| ACKNOWLEDGMENTS |
|---|
We acknowledge the vital contributions of the following colleagues to this work: Phil Amess, Anthony Costello, David Edwards, Peter Hope, Pat Hamilton, Vincent Kirkbride, David McCormick, Judith Meeks, Juliet Penrice, Jan Townsend, the staff of the Neonatal Unit of University College Hospital, and the parents and children for their cooperation.
| FOOTNOTES |
|---|
Reprint requests to (B.V.) Institute of Child Health, Neurosciences Unit, University College London Medical School, Mecklenburgh Square, London WC 1N 2AP, United Kingdom. E-mail: b.vollmer{at}ich.ucl.ac.uk
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. U.J. Mewes, P. S. Huppi, H. Als, F. J. Rybicki, T. E. Inder, G. B. McAnulty, R. V. Mulkern, R. L. Robertson, M. J. Rivkin, and S. K. Warfield Regional Brain Development in Serial Magnetic Resonance Imaging of Low-Risk Preterm Infants Pediatrics, July 1, 2006; 118(1): 23 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pisani, L. Leali, S. Moretti, E. Turco, E. Volante, and G. Bevilacqua Transient Periventricular Echodensities in Preterms and Neurodevelopmental Outcome J Child Neurol, March 1, 2006; 21(3): 230 - 236. [Abstract] [PDF] |
||||
![]() |
P.-Y. Ancel, F. Livinec, B. Larroque, S. Marret, C. Arnaud, V. Pierrat, M. Dehan, S. N'Guyen, B. Escande, A. Burguet, et al. Cerebral Palsy Among Very Preterm Children in Relation to Gestational Age and Neonatal Ultrasound Abnormalities: The EPIPAGE Cohort Study Pediatrics, March 1, 2006; 117(3): 828 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Markestad, P. I. Kaaresen, A. Ronnestad, H. Reigstad, K. Lossius, S. Medbo, G. Zanussi, I. E. Engelund, R. Skjaerven, L. M. Irgens, et al. Early Death, Morbidity, and Need of Treatment Among Extremely Premature Infants Pediatrics, May 1, 2005; 115(5): 1289 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
Other articles noted: 14 Nov 2003 to 30 Jan 2004 Evid. Based Nurs., April 1, 2004; 7(2): e2 - e2. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||